COVID-19-related severe MS exacerbation with life-threatening Takotsubo cardiomyopathy in a previously stable patient and interference of MS therapy with long-term immunity against SARS-CoV-2

[1]  A. Chockalingam,et al.  Takotsubo Syndrome in Patients with COVID-19: a Systematic Review of Published Cases , 2020, SN Comprehensive Clinical Medicine.

[2]  F. Paul,et al.  Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients , 2020, Journal of Neuroinflammation.

[3]  F. Paul,et al.  Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients , 2020, Journal of Neuroinflammation.

[4]  L. Krupp,et al.  COVID-19 outcomes in MS , 2020, Neurology: Neuroimmunology & Neuroinflammation.

[5]  D. Wingerchuk,et al.  The spectrum of acute cardiopulmonary events associated with multiple sclerosis exacerbations , 2019, Multiple sclerosis.

[6]  J. Correale,et al.  The role of infections in multiple sclerosis , 2019, Multiple sclerosis.

[7]  F. London,et al.  Reverse takotsubo cardiomyopathy triggered by a multiple sclerosis relapse , 2018, Acta Neurologica Belgica.

[8]  Jacqueline Palace,et al.  MOG encephalomyelitis: international recommendations on diagnosis and antibody testing , 2018, Journal of Neuroinflammation.

[9]  H. Shimokawa,et al.  Multiple sclerosis lesion in the medulla oblongata in a patient with takotsubo cardiomyopathy. , 2016, International journal of cardiology.

[10]  F. Paul,et al.  MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome , 2016, Journal of Neuroinflammation.

[11]  F. Paul,et al.  MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin , 2016, Journal of Neuroinflammation.

[12]  À. Rovira,et al.  An uncommon first manifestation of multiple sclerosis: Tako-Tsubo cardiomyopathy , 2016, Multiple sclerosis.

[13]  K. Wandinger,et al.  Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen , 2010, Journal of the Neurological Sciences.

[14]  G. Akman-Demir,et al.  The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature , 2016, Journal of Neurology.